These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 387069)

  • 21. [Clinical and biological justifications for the use of Triella].
    McGuire JL; Pasquale SA; Castaigne JP
    Rev Fr Gynecol Obstet; 1986 Dec; 81(12):731-6. PubMed ID: 3823727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The expediency of using natural oestrogens in combined oral contraceptive tablets].
    Kovacs L; Zalanyi S; Tekulics A; Sas M
    Orvoskepzes; 1983 Mar; 58(2):99-103. PubMed ID: 12312969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical results with a new low dose oral contraceptive utilizing norethindrone/ethinyl estradiol.
    Pasquale SA; Yuliano E
    Contraception; 1975 Nov; 12(5):495-503. PubMed ID: 1192736
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of varying amounts of ethinyl oestradiol in the combined oral contraceptive on plasma sex hormone binding globulin capacity in normal women.
    Pogmore JR; Jequier AM
    Br J Obstet Gynaecol; 1979 Jul; 86(7):563-7. PubMed ID: 573132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant hypertension and oral contraceptives: four cases, with two due to the 30 micrograms oestrogen pill.
    Hodsman GP; Robertson JI; Semple PF; Mackay A
    Eur Heart J; 1982 Jun; 3(3):255-9. PubMed ID: 6809465
    [No Abstract]   [Full Text] [Related]  

  • 28. Early symptoms and discontinuation among users of oral contraceptives in Sri Lanka.
    Basnayake S; Higgins JE; Miller PC; Rogers SM; Kelly SE
    Stud Fam Plann; 1984; 15(6 Pt 1):285-90. PubMed ID: 6393460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natural oestrogenic hormone oestradiol as a new component of combined oral contraceptives.
    Astedt B; Svanberg L; Jeppsson S; Liedholm P; Rannevik G
    Br Med J; 1977 Jan; 1(6056):269. PubMed ID: 319864
    [No Abstract]   [Full Text] [Related]  

  • 31. An open assessment of a new low dose oestrogen combined oral contraceptive.
    Hughes I
    J Int Med Res; 1978; 6(1):41-5. PubMed ID: 627304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biphasic versus monophasic oral contraceptives for contraception.
    Van Vliet HA; Grimes DA; Helmerhorst FM; Schulz KF
    Cochrane Database Syst Rev; 2003; (2):CD002032. PubMed ID: 12804421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A continuous experience of the use of norethindrone-ethinyl estradiol combination in small doses as a contraceptive].
    Ruíz Moreno JA; Rubio Lotvin B; Bolio Arista R; de Larios NM
    Ginecol Obstet Mex; 1977 Feb; 41(244):179-84. PubMed ID: 321297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
    Hellberg D; Nilsson S
    Maturitas; 1984 Apr; 5(4):233-43. PubMed ID: 6429481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary experience with a 'sub-50' combined oral contraceptive, containing 35 micrograms ethinyl oestradiol and 1 mg norethisterone ('NeoCon').
    Schellen AM
    Pharmatherapeutica; 1980; 2(6):412-5. PubMed ID: 7433480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
    Molina RC; Sandoval JZ; Montero AV; Oyarzún PG; Molina TG; González EA
    J Pediatr Adolesc Gynecol; 2009 Feb; 22(1):25-31. PubMed ID: 19232299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.